1.75
1.75 (0%)
As of Feb 14, 2025
Theratechnologies Inc. [THTX]
Source:
Company Overview
Theratechnologies Inc. is a specialty biopharmaceutical company focused on the commercialization of innovative therapies that have the potential to redefine standards of care.
| Country | Canada |
| Headquarters | montreal |
| Phone Number | 514-336-7800 |
| Industry | manufacturing |
| CEO | Paul L Vesque |
| Website | www.theratech.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $85.9 |
| Operating Profit | |
| Net Income | $-8.3 |
| Net Cash | $-18.2 |
Profit Ratios
| Gross Margin | $65.4 |
| Operating Margin | |
| Profit as % of Revenues | -787.6% |
| Profit as % of Assets | -12.7% |
| Profit as % of Stockholder Equity | 32.9% |
Management Effectiveness
| Return on Equity | 32.9% |
| Return on Assets | -15.6% |
| Turnover Ratio | 131% |
| EBITA | $0 |
Balance Sheet and Cash Flow Measures
| Total Assets | $53.3 |
| Total Liabilities | $78.6 |
| Operating Cash Flow | $2.4 |
| Investing Cash Flow | $0.9 |
| Financing Cash Flow | $-21.5 |
